Fig. 4From: Cisplatin-based concurrent chemoradiotherapy improved the survival of locoregionally advanced nasopharyngeal carcinoma after induction chemotherapy by reducing early treatment failureTime-specific treatment failure probabilities (A), locoregional failure (B), and distant failure probabilities (C) in 3123 nasopharyngeal carcinoma patients stratified by CCD = 0 mg/m2, CCD 1-200 mg/m2, and CCD 200 mg/m2 Back to article page